Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension

Journal of Cardiovascular Pharmacology

Volumn 35, Issue 6, 2000, Pages 937-941

  Stergiou, George S ^a   Skeva, Irini I ^a   Baibas, Nikolaos M ^a   Roussias, Leonidas G ^a   Kalkana, Chrysa B ^a   Achimastos, Apostolos D ^a   Mountokalakis, Theodore D ^a  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

Angiotensin converting enzyme inhibition; Angiotensin receptor antagonism combination; Benazepril; Essential hypertension; Valsartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; RENIN; VALSARTAN;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG POTENCY; DRUG POTENTIATION; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; HUMAN; MALE; MONOTHERAPY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENZAZEPINES; BLOOD PRESSURE; CROSS-OVER STUDIES; DIASTOLE; DOUBLE-BLIND METHOD; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; SYSTOLE; TETRAZOLES; TIME FACTORS; VALINE;

EID: 0034074198     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200006000-00017     Document Type: Article

References (5)

1. Birkenhager WH, de Leeuw PW. Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension. J Hypertens 1999;17:873-81.
2. 1999 World Health Organisation. International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151-83.
3. Fossa AA, DePasquale MJ, Ringer LJ, Winslow RL. Synergistic effect on reduction in blood pressure with coadministration of a renin inhibitor or an angiotensin convening enzyme inhibitor with an angiotensin II receptor antagonist. Drug Dev Res 1994;33:422-8.
4. Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Menard J. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation 1995;92:825-34.
5. Azizi M, Guyene TT, Chatellier G, Wargon M, Menard J. Additive effects of losartan and enalapril on blood pressure and plasma active renin. Hypertension 1997;29:634-40.